• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局限性硬皮病和弥漫性硬皮病中的 microRNA 表达异常。

MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma.

机构信息

Department of Rheumatology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, 410008, People's Republic of China.

出版信息

J Clin Immunol. 2012 Jun;32(3):514-22. doi: 10.1007/s10875-011-9647-y. Epub 2012 Feb 4.

DOI:10.1007/s10875-011-9647-y
PMID:22307526
Abstract

Scleroderma (systemic sclerosis, SSc) is a complex autoimmune disease caused by progressive fibrotic replacement of normal tissue architecture, a progressive and ultimately fatal process that currently has no cure. Although dysregulation of microRNAs (miRNAs) is known to be involved in a variety of pathophysiologic processes, the role of miRNAs in SSc is unclear. In comparison with the normal skin tissues, miRNAs were aberrantly expressed in limited cutaneous scleroderma and diffuse cutaneous scleroderma skin tissues. We also identified miRNAs whose expressions were correlated with SSc fibrosis: miR-21, miR-31, miR-146, miR-503, miR-145, and miR-29b were predicted to be involved. This study further confirmed that miR-21 was increased whereas miR-145 and miR-29b were decreased both in the skin tissues and fibroblasts. As predicted target genes, SMAD7, SAMD3, and COL1A1 were regulated by these miRNAs. After stimulation with transforming growth factor β, the expression of miR-21 was increased and that of SMAD7 mRNA was decreased. MiR-145 was upregulated whereas the mRNA level of SMAD3 was downregulated. The downregulation of miR-29b was correlated with the upregulation of COL1A1 mRNA. MiRNAs might play an important role in the pathogenesis of SSc and suggest a potential therapy.

摘要

硬皮病(系统性硬皮病,SSc)是一种复杂的自身免疫性疾病,由正常组织结构的进行性纤维化替代引起,是一个进行性的、最终致命的过程,目前尚无治愈方法。尽管已知 microRNAs(miRNAs)的失调参与了多种病理生理过程,但 miRNAs 在 SSc 中的作用尚不清楚。与正常皮肤组织相比,局限性硬皮病和弥漫性硬皮病皮肤组织中 miRNAs 的表达出现异常。我们还鉴定了与 SSc 纤维化相关的表达受调控的 miRNAs:miR-21、miR-31、miR-146、miR-503、miR-145 和 miR-29b 被预测为参与其中。本研究进一步证实,miR-21 在皮肤组织和成纤维细胞中均增加,而 miR-145 和 miR-29b 均减少。作为预测的靶基因,SMAD7、SAMD3 和 COL1A1 受这些 miRNAs 调节。转化生长因子 β 刺激后,miR-21 的表达增加,SMAD7 mRNA 的表达减少。miR-145 上调,而 SMAD3 mRNA 的表达下调。miR-29b 的下调与 COL1A1 mRNA 的上调相关。miRNAs 可能在 SSc 的发病机制中发挥重要作用,并提示一种潜在的治疗方法。

相似文献

1
MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma.局限性硬皮病和弥漫性硬皮病中的 microRNA 表达异常。
J Clin Immunol. 2012 Jun;32(3):514-22. doi: 10.1007/s10875-011-9647-y. Epub 2012 Feb 4.
2
Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β.SSc 中循环 miRNA 的改变:miR-30b 调节 PDGF 受体 β 的表达。
Rheumatology (Oxford). 2013 Nov;52(11):1963-72. doi: 10.1093/rheumatology/ket254. Epub 2013 Jul 27.
3
MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression.硬皮病纤维化中的 microRNA-21 及其在 TGF-β 调控的纤维化相关基因表达中的功能。
J Clin Immunol. 2013 Aug;33(6):1100-9. doi: 10.1007/s10875-013-9896-z. Epub 2013 May 9.
4
TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.TGF-β 介导的 microRNA-196a 下调导致硬皮病皮肤成纤维细胞中 I 型胶原的组成性上调。
J Immunol. 2012 Apr 1;188(7):3323-31. doi: 10.4049/jimmunol.1100876. Epub 2012 Feb 29.
5
MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis.微小 RNA-21 和微小 RNA-29a 调节系统性硬皮病患者真皮成纤维细胞中胶原蛋白的表达。
Autoimmunity. 2019 May;52(3):108-116. doi: 10.1080/08916934.2019.1621856. Epub 2019 Jun 3.
6
microRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma.硬皮病患者血清和真皮成纤维细胞中的 microRNA-92a 表达增加。
Rheumatology (Oxford). 2012 Sep;51(9):1550-6. doi: 10.1093/rheumatology/kes120. Epub 2012 Jun 1.
7
Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.脂肪细胞素在弥漫性硬皮病患者受累皮肤和血清中的表达降低。
Exp Dermatol. 2011 Sep;20(9):764-6. doi: 10.1111/j.1600-0625.2011.01310.x. Epub 2011 May 25.
8
Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.硬皮病角质形成细胞可促进成纤维细胞活化,且不依赖于转化生长因子β 。
Rheumatology (Oxford). 2017 Nov 1;56(11):1970-1981. doi: 10.1093/rheumatology/kex280.
9
Dysregulated interleukin-23 signalling contributes to the increased collagen production in scleroderma fibroblasts via balancing microRNA expression.白细胞介素-23信号失调通过平衡微小RNA表达,导致硬皮病成纤维细胞中胶原蛋白生成增加。
Rheumatology (Oxford). 2017 Jan;56(1):145-155. doi: 10.1093/rheumatology/kew336. Epub 2016 Oct 15.
10
Expression analysis of multiple microRNAs in each patient with scleroderma.每位硬皮病患者多种 microRNAs 的表达分析。
Exp Dermatol. 2013 Jul;22(7):489-91. doi: 10.1111/exd.12173.

引用本文的文献

1
MicroRNAs in Systemic Sclerosis: Involvement in Disease Pathogenesis and Potential Use as Diagnostic Biomarkers and Therapeutic Targets.系统性硬化症中的微小RNA:参与疾病发病机制及作为诊断生物标志物和治疗靶点的潜在用途。
Biomedicines. 2025 May 16;13(5):1216. doi: 10.3390/biomedicines13051216.
2
Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency.凋亡小体通过恢复 miR-145a-5p 的缺乏来挽救受损的间充质干细胞及其治疗骨质疏松症的能力。
J Nanobiotechnology. 2024 Sep 20;22(1):580. doi: 10.1186/s12951-024-02829-2.
3
Virus-Induced MicroRNA Modulation and Systemic Sclerosis Disease.

本文引用的文献

1
Circulating miR-29a levels in patients with scleroderma spectrum disorder.硬皮病谱系障碍患者循环miR-29a水平
J Dermatol Sci. 2011 Jan;61(1):67-9. doi: 10.1016/j.jdermsci.2010.11.007. Epub 2010 Nov 16.
2
MicroRNA array analysis of microRNAs related to systemic scleroderma.系统性硬皮病相关 microRNAs 的 miRNA 芯片分析。
Rheumatol Int. 2012 Feb;32(2):307-13. doi: 10.1007/s00296-010-1615-y. Epub 2010 Oct 30.
3
MicroRNAs and the regulation of fibrosis.微小 RNA 与纤维化的调控。
病毒诱导的微小RNA调控与系统性硬化症
Biomedicines. 2024 Jun 19;12(6):1360. doi: 10.3390/biomedicines12061360.
4
Apoptotic vesicles rescue impaired mesenchymal stem cells and their therapeutic capacity for osteoporosis by restoring miR-145a-5p deficiency.凋亡小泡通过恢复miR-145a-5p缺乏来挽救受损的间充质干细胞及其对骨质疏松症的治疗能力。
Res Sq. 2024 Jun 4:rs.3.rs-4416138. doi: 10.21203/rs.3.rs-4416138/v1.
5
MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling.miR-21a-5p 通过靶向 STAT3 信号通路缓解系统性硬化症。
J Transl Med. 2024 Apr 1;22(1):323. doi: 10.1186/s12967-024-05056-3.
6
Perspective to precision medicine in scleroderma.硬皮病精准医学的展望。
Front Immunol. 2024 Jan 18;14:1298665. doi: 10.3389/fimmu.2023.1298665. eCollection 2023.
7
Oxidative Stress and Epigenetics: miRNA Involvement in Rare Autoimmune Diseases.氧化应激与表观遗传学:微小RNA在罕见自身免疫性疾病中的作用
Antioxidants (Basel). 2023 Mar 25;12(4):800. doi: 10.3390/antiox12040800.
8
Bioinformatics-integrated screening of systemic sclerosis-specific expressed markers to identify therapeutic targets.生物信息学综合筛选系统性硬皮病特异性表达标志物以鉴定治疗靶点。
Front Immunol. 2023 Mar 30;14:1125183. doi: 10.3389/fimmu.2023.1125183. eCollection 2023.
9
Mechanisms and application strategies of miRNA‑146a regulating inflammation and fibrosis at molecular and cellular levels (Review).miRNA-146a 在分子和细胞水平上调节炎症和纤维化的机制及应用策略(综述)。
Int J Mol Med. 2023 Jan;51(1). doi: 10.3892/ijmm.2022.5210. Epub 2022 Dec 9.
10
Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases.自身免疫性和炎症性皮肤病中的表观遗传失调。
Clin Rev Allergy Immunol. 2022 Dec;63(3):447-471. doi: 10.1007/s12016-022-08956-8. Epub 2022 Nov 8.
FEBS J. 2010 May;277(9):2015-21. doi: 10.1111/j.1742-4658.2010.07632.x.
4
MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.微小RNA-29,系统性硬化症中胶原蛋白表达的关键调节因子。
Arthritis Rheum. 2010 Jun;62(6):1733-43. doi: 10.1002/art.27443.
5
Physiological and pathological roles for microRNAs in the immune system.miRNAs 在免疫系统中的生理和病理作用。
Nat Rev Immunol. 2010 Feb;10(2):111-22. doi: 10.1038/nri2708.
6
A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity.TGFbeta 反应基因特征与弥漫性硬皮病的一个亚组相关,该亚组疾病严重程度增加。
J Invest Dermatol. 2010 Mar;130(3):694-705. doi: 10.1038/jid.2009.318. Epub 2009 Oct 8.
7
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications.利用和拮抗微小RNA调控以用于治疗和实验应用。
Nat Rev Genet. 2009 Aug;10(8):578-85. doi: 10.1038/nrg2628.
8
Scleroderma.硬皮病
N Engl J Med. 2009 May 7;360(19):1989-2003. doi: 10.1056/NEJMra0806188.
9
Toward microRNA-based therapeutics for heart disease: the sense in antisense.迈向基于微小RNA的心脏病治疗:反义中的意义。
Circ Res. 2008 Oct 24;103(9):919-28. doi: 10.1161/CIRCRESAHA.108.183426.
10
LNA-mediated microRNA silencing in non-human primates.非人灵长类动物中锁核酸介导的微小RNA沉默
Nature. 2008 Apr 17;452(7189):896-9. doi: 10.1038/nature06783. Epub 2008 Mar 26.